Cargando…

Macular impairment in mitochondrial diseases: a potential biomarker of disease severity

The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than r...

Descripción completa

Detalles Bibliográficos
Autores principales: Primiano, Guido, Abed, Edoardo, Corbo, Giovanni, Minnella, Angelo Maria, Servidei, Serenella, Vollono, Catello, Savastano, Maria Cristina, Falsini, Benedetto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244507/
https://www.ncbi.nlm.nih.gov/pubmed/32444699
http://dx.doi.org/10.1038/s41598-020-65482-3
_version_ 1783537588081000448
author Primiano, Guido
Abed, Edoardo
Corbo, Giovanni
Minnella, Angelo Maria
Servidei, Serenella
Vollono, Catello
Savastano, Maria Cristina
Falsini, Benedetto
author_facet Primiano, Guido
Abed, Edoardo
Corbo, Giovanni
Minnella, Angelo Maria
Servidei, Serenella
Vollono, Catello
Savastano, Maria Cristina
Falsini, Benedetto
author_sort Primiano, Guido
collection PubMed
description The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than rods. A cohort of twenty-two patients with genetically-defined mitochondrial diseases (MDs) were enrolled to determine if the macula is functionally and anatomically impaired in these metabolic disorders. Visual acuity and fERG amplitude of patients with primary mitochondrial dysfunction were reduced compared to controls. Furthermore, SD-OCT layer segmentation showed a reduction of retinal and outer nuclear layer (ONL) volume in the macula of the patients. fERG amplitude showed a positive correlation with both ONL volume and thickness. A negative relationship was noted between fERG amplitude and disease severity assessed with Newcastle Mitochondrial Disease Adult Scale. In conclusion, MDs are associated with functional and anatomical alteration of macular cone system, characterized by its strong correlation with clinical disease severity suggesting a role as a potential biomarker of primary mitochondrial disorders.
format Online
Article
Text
id pubmed-7244507
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72445072020-05-30 Macular impairment in mitochondrial diseases: a potential biomarker of disease severity Primiano, Guido Abed, Edoardo Corbo, Giovanni Minnella, Angelo Maria Servidei, Serenella Vollono, Catello Savastano, Maria Cristina Falsini, Benedetto Sci Rep Article The high-energy demands of the retina are thought to contribute to its particular vulnerability to mitochondrial dysfunction. Photoreceptors are the cells with the higher oxygen consumption within the retina, and among these, the cones contain more mitochondria and have a higher energy demand than rods. A cohort of twenty-two patients with genetically-defined mitochondrial diseases (MDs) were enrolled to determine if the macula is functionally and anatomically impaired in these metabolic disorders. Visual acuity and fERG amplitude of patients with primary mitochondrial dysfunction were reduced compared to controls. Furthermore, SD-OCT layer segmentation showed a reduction of retinal and outer nuclear layer (ONL) volume in the macula of the patients. fERG amplitude showed a positive correlation with both ONL volume and thickness. A negative relationship was noted between fERG amplitude and disease severity assessed with Newcastle Mitochondrial Disease Adult Scale. In conclusion, MDs are associated with functional and anatomical alteration of macular cone system, characterized by its strong correlation with clinical disease severity suggesting a role as a potential biomarker of primary mitochondrial disorders. Nature Publishing Group UK 2020-05-22 /pmc/articles/PMC7244507/ /pubmed/32444699 http://dx.doi.org/10.1038/s41598-020-65482-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Primiano, Guido
Abed, Edoardo
Corbo, Giovanni
Minnella, Angelo Maria
Servidei, Serenella
Vollono, Catello
Savastano, Maria Cristina
Falsini, Benedetto
Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_full Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_fullStr Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_full_unstemmed Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_short Macular impairment in mitochondrial diseases: a potential biomarker of disease severity
title_sort macular impairment in mitochondrial diseases: a potential biomarker of disease severity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244507/
https://www.ncbi.nlm.nih.gov/pubmed/32444699
http://dx.doi.org/10.1038/s41598-020-65482-3
work_keys_str_mv AT primianoguido macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT abededoardo macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT corbogiovanni macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT minnellaangelomaria macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT servideiserenella macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT vollonocatello macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT savastanomariacristina macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity
AT falsinibenedetto macularimpairmentinmitochondrialdiseasesapotentialbiomarkerofdiseaseseverity